)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
Enorama Pharma (ERMA) investor relations material
Enorama Pharma Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary20 Aug, 2025
Executive summary
Revenue for Q2 2025 was 733 KSEK, down 87% year-over-year, mainly due to a change in US distributor and minimal sales activity during the transition.
Operating loss widened to -15,321 KSEK in Q2 and -31,999 KSEK for H1 2025, reflecting higher PMTA costs, inventory write-downs, and negative currency effects.
Strategic focus remains on the PMTA process for permanent FDA approval and building a new commercial platform in the US.
Financial highlights
Q2 2025 net sales: 733 KSEK (5,656 KSEK Q2 2024); H1 2025 net sales: 1,182 KSEK (5,646 KSEK H1 2024).
Q2 2025 operating result: -15,321 KSEK (-6,340 KSEK Q2 2024); H1 2025: -31,999 KSEK (-16,366 KSEK H1 2024).
Q2 2025 pre-tax result: -18,708 KSEK (-6,767 KSEK Q2 2024); H1 2025: -41,219 KSEK (-14,673 KSEK H1 2024).
Inventory write-downs in H1: -10,330 KSEK; PMTA costs: -6,021 KSEK; currency losses: -8,696 KSEK.
Equity at June 30, 2025: 8,279 KSEK (38,754 KSEK June 2024); liquidity: 2,518 KSEK (17,376 KSEK June 2024).
Outlook and guidance
Expectation of resumed sales growth in the US from September 2025 with a new distributor and commercial director.
Continued investment in PMTA process, with further capital needed to complete FDA approval.
US market for white snus remains a significant growth opportunity.
How will PMTA process be fully funded?
US market strategy with multiple partners?
Non-cash costs impact on Q2/H1 results?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Enorama Pharma earnings date
Q3 202519 Nov, 2025
Next Enorama Pharma earnings date
Q3 202519 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
Enorama Pharma AB is a pharmaceutical company headquartered in Malmö, Sweden. The company focuses on developing and manufacturing medicated chewing gum and other nicotine products. Its main products include nicotine chewing gums and pouches aimed at aiding smoking cessation. Enorama Pharma also explores other applications such as medical cannabis chewing gums and oromucosal drug delivery systems. The company operates with a commitment to providing innovative pharmaceutical solutions. Enorama Pharma is listed on the Stockholm Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage